好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Switching between Immediate- and Extended-Release Formulations Does Not Affect the Steady-State Pharmacokinetic Profile of Topiramate
Epilepsy
(-)
112
Authors/Disclosures
Lawrence Lambrecht, PharmD (Upsher-Smith Laboratories, Inc) No disclosure on file
No disclosure on file
Wesley M. Todd, MD No disclosure on file
Mark Halvorsen, PharmD (Upsher-Smith Laboratories, LLC) Dr. Halvorsen has received personal compensation for serving as an employee of Upsher-Smith Laboratories, LLC. Dr. Halvorsen has stock in Pfizer. Dr. Halvorsen has stock in Amgen. Dr. Halvorsen has stock in Stryker.
David Lacomis, MD, FAAN (UPMC Neurology) Dr. Lacomis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. The institution of Dr. Lacomis has received research support from Mitsubishi Tanabe. The institution of Dr. Lacomis has received research support from NIH. Dr. Lacomis has received publishing royalties from a publication relating to health care.
No disclosure on file